Z. Lu

Feb 7, 2024 | onlinelibrary.wiley.com | Jing Yuan |Z. Lu |Minghui Li |Jingwen Bai

1 INTRODUCTION Stroke is the leading cause of death globally, posing enormous clinical and economic burdens to patients, families, and society.1 According to the American Heart Association/American Stroke Association,2 endovascular thrombectomy (EVT) is standard care for eligible patients with Acute ischemic stroke (AIS) within 6 h of onset.

May 12, 2023 | nature.com | Jing Yuan |Minghui Li |Z. Lu

Between 2016 and 2022, 83 previously approved oncology drugs were covered and reimbursed in China through a value-based pricing negotiation programme, which resulted in substantial price cuts but did not improve the correlation between drug cost and clinical benefit. Herein, we call for an improved, transparent value-based pricing model to better account for high-value innovation in oncology drugs.